BioCentury
ARTICLE | Company News

Servier, Pfizer deal

November 23, 2015 8:00 AM UTC

Servier granted Pfizer exclusive, worldwide co-development rights and U.S. commercialization rights to UCART19. The partners will work together on a joint clinical development program for UCART19 and...